Common Contracts

Italfarmaco Enters Binding Term Sheet Agreement with Neupharma for an Exclusive Option to Develop and Commercialize Inhaled Teicoplanin

Binding Term Sheet Agreement • August 1st, 2019

• Contract Type
  Binding Term Sheet Agreement
• Filed
  August 1st, 2019

Fabio Borella, President and Co-founder of Neupharma added, “We believe Italfarmaco has the right resources and development expertise that will enable the inhaled formulation of teicoplanin to successfully enter the next stages of clinical development and ideally commercialization. On the whole we value the opportunity to collaborate with this well-established organization.”